Recombinant monoclonal antibodies have gained significant importance in diagnostic and therapeutic applications over the past years. In order to verify the correctness of the overall molecule to provide a reproducible, safe and effective biological drug compound, the correct protein sequence as well as the presence and relative abundance of different glycoforms have to be confirmed.